|
[1]
|
Cybulska, B. and Klosiewicz-Latoszek, L. (2019) Landmark Studies in Coronary Heart Disease Epidemiology. The Framingham Heart Study after 70 Years and the Seven Countries Study after 60 Years. Kardiologia Polska, 77, 173-180. [Google Scholar] [CrossRef]
|
|
[2]
|
肖文强. 预防性冠状动脉内注射尼可地尔对急性ST段抬高型心肌梗死介入治疗后心肌血流灌注及预后的影响[J]. 实用医技杂志, 2019, 26(5): 629-630.
|
|
[3]
|
陈韵岱, 王建安, 刘斌, 等. 药物涂层球囊临床应用中国专家共识[J]. 中国介入心脏病学杂志, 2016, 24(2): 61-67.
|
|
[4]
|
Serruys, P.W., Morice, M.C., Kappetein, A.P., et al. (2009) Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. The New England Journal of Medicine, 360, 961-972. [Google Scholar] [CrossRef]
|
|
[5]
|
王志清, 陈梅贤, 刘东林, 等. 预防性冠状动脉内注射尼可地尔对急性ST 段抬高型心肌梗死介入治疗后心肌血流灌注及预后的影响[J]. 中华心血管病杂志, 2017, 45(1): 26-33.
|
|
[6]
|
Kloner, R.A., Rude, R.E., Carlson, N., et al. (1980) Ultrastructural Evidence of Microvascular Damage and Myocardial cell Injury after Coronary Artery Occlusion: Which Comes First? Circulation, 62, 945-952. [Google Scholar] [CrossRef]
|
|
[7]
|
Kloner, R.A., Ganote, C.E. and Jennings, R.B. (1974) The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the Dog. Journal of Clinical Investigation, 54, 1496-1508. [Google Scholar] [CrossRef]
|
|
[8]
|
Kobatake, R., Sato, T., Fujiwara, Y., et al. (211) Comparison of the Effects of Nitroprusside versus Nicorandil on the Slow/No-Reflow Phenomenon during Coronary Interventions for Acute Myocardial Infarction. Heart and Vessels, 26, 379-384. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Rezkalla, S.H., Dharmashankar, K.C., Abdalrahman, I.B., et al. (2010) No-Reflow Phenomenon following Percutaneous Coronary Intervention for Acute Myocardial Infarction: Inci-dence, Outcome, and Effect of Pharmacologic Therapy. Journal of Interventional Cardiology, 23, 429-436. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Leu, H.B., Lin, C.P., Lin, W.T., et al. (2006) Circulating Mononuclear Superoxide Production and Inflammatory Markers for Long-Term Prognosis in Patients with Cardiac Syn-drome X. Free Radical Biology and Medicine, 40, 983-991. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lin, C.P., Lin, W.T., Leu, H.B., Wu, T.C. and Chen, J.W. (2003) Differential Mononuclear Cell Activity and Endothelial Inflammation in Coronary Artery Disease and Cardiac Syndrome X. International Journal of Cardiology, 89, 53-62. [Google Scholar] [CrossRef]
|
|
[12]
|
Signori, L.U., Quadros, A.S., Sbruzzi, G., et al. (2012) En-dothelial Function in Patients with Slow Coronary Flow and Normal Coronary Angiography. Clinics, 67, 677-680. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhao, J., Zhang, Y., Huang, Z., et al. (2020) Association between Impaired Cutaneous Microvascular Endothelial Function and Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Patients with Coronary Slow Flow. Microvascular Research, 129, Article ID: 103984. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Camici, P.G. and Crea, F. (2007) Coronary Microvascular Dys-function. The New England Journal of Medicine, 356, 830-840. [Google Scholar] [CrossRef]
|
|
[15]
|
Willerson, J.T., Watson, J.T., Hutton, I., et al. (1975) Reduced Myo-cardial Reflow and Increased Coronary Vascular Resistance following Prolonged Myocardial Ischemia in the Dog. Cir-culation Research, 36, 771-781. [Google Scholar] [CrossRef]
|
|
[16]
|
Feigl, E.O. (1983) Coronary Physiology. Physiological Reviews, 63, 1-205. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Kuo, L., Davis, M.J. and Chilian, W.M. (1990) Endotheli-um-Dependent, Flow-Induced Dilation of Isolated Coronary Arterioles. American Journal of Physiology-Heart and Cir-culatory Physiology, 259, H1063-H1070. [Google Scholar] [CrossRef]
|
|
[18]
|
Callera, G., Tostes, R., Savoia, C., et al. (2007) Vasoactive Peptides in Cardiovascular (Patho) Physiology. Expert Review of Cardiovascular Therapy, 5, 531-552. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Kenney, W.L., Cannon, J.G. and Alexander, L.M. (2013) Cutane-ous Microvascular Dysfunction Correlates with Serum LDL and sLOX-1 Receptor Concentrations. Microvascular Re-search, 85, 112-117. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Sezgin, A.T., Sigirci, A., Barutcu, I., et al. (2003) Vascular Endo-thelial Function in Patients with Slow Coronary Flow. Coronary Artery Disease, 14, 155-161. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Yurtdas, M., Yaylali, Y.T., Kaya, Y., et al. (2014) In-creased Plasma High-Sensitivity C-Reactive Protein and Myeloperoxidase Levels May Predict Ischemia during Myocar-dial Perfusion Imaging in Slow Coronary Flow. Archives of Medical Research, 45, 63-69. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Raedschelders, K., Ansley, D.M. and Chen, D.D. (2012) The Cellular and Molecular Origin of Reactive Oxygen Species Generation during Myocardial Ischemia and Reperfusion. Pharmacology & Therapeutics, 133, 230-255. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Kleinbongard, P., Konorza, T., Bose, D., et al. (2012) Les-sons from Human Coronary Aspirate. Journal of Molecular and Cellular Cardiology, 52, 890-896. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Silvain, J., Collet, J.P., Nagaswami, C., et al. (2011) Composition of Coronary Thrombus in Acute Myocardial Infarction. Journal of the American College of Cardiology, 57, 1359-1367. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Eguchi, H., Ikeda, H., Murohara, T., et al. (1999) Endothelial Inju-ries of Coronary Arteries Distal to Thrombotic Sites: Role of Adhesive Interaction between Endothelial P-Selectin and Leukocyte Sialyl LewisX. Circulation Research, 84, 525-535. [Google Scholar] [CrossRef]
|
|
[26]
|
Funayama, H., Ishikawa, S.E., Sugawara, Y., et al. (2010) Myelop-eroxidase May Contribute to the No-Reflow Phenomenon in Patients with Acute Myocardial Infarction. International Journal of Cardiology, 139, 187-192. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
赵翠婷. HOXD9/MALAT1/miR-181b-5p/MEF2A信号轴调控冠状动脉慢血流血管内皮功能机制研究[D]: [博士学位论文]. 沈阳: 中国医科大学, 2021.
|
|
[28]
|
朱晴. NEAT1/miR-148b-3p/ICAM-1途径在调节冠状动脉慢血流血管内皮细胞炎症反应中的机制研究[D]: [博士学位论文]. 沈阳: 中国医科大学, 2022.
|
|
[29]
|
孙理华, 幸世峰, 张颖, 等. 冠状动脉慢血流疾病转录组学研究及差异基因验证[J]. 中华心血管病杂志, 2021, 49(12): 1206-1212.
|
|
[30]
|
Hamirani, Y.S., Wong, A., Kramer, C.M., et al. (2014) Effect of Microvascular Obstruction and Intramyocardial Hemorrhage by CMR on LV Remodeling and Outcomes after Myocardial Infarction: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging, 7, 940-952. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Niu, X., Zhang, J., Bai, M., et al. (2018) Effect of Intracoronary Agents on the No-Reflow Phenomenon during Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction: A Network Meta-Analysis. BMC Cardiovascular Disorders, 18, Article No. 3. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Poupko, J.M., Baskin, S.I. and Moore, E. (2007) The Pharmaco-logical Properties of Anisodamine. Journal of Applied Toxicology, 27, 116-121. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Norby, F.L. and Ren, J. (2002) Anisodamine Inhibits Cardiac Contraction and Intracellular Ca2+ Transients in Isolated Adult Rat Ventricular Myocytes. European Journal of Pharmacology, 439, 21-25. [Google Scholar] [CrossRef]
|
|
[34]
|
Xing, K., Fu, X., Jiang, L., et al. (2015) Cardioprotective Ef-fect of Anisodamine against Myocardial Ischemia Injury and Its Influence on Cardiomyocytes Apoptosis. Cell Biochem-istry and Biophysics, 73, 707-716. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Hottinger, D.G., Beebe, D.S., Kozhimannil, T., Prielipp, R.C. and Belani, K.G. (2014) Sodium Nitroprusside in 2014: A Clinical Concepts Review. Journal of Anaesthesiology Clinical Pharmacology, 30, 462-471. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Kumbhani, D.J. and de Lemos, J.A. (2016) Finding an Effective Treatment for Microvascular Obstruction in STEMI: A Road to Perdition? European Heart Journal, 37, 1920-1922. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Brogden, R.N. and Benfield, P. (1996) Verapamil: A Review of Its Pharmacological Properties and Therapeutic Use in Coronary Artery Disease. Drugs, 51, 792-819. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Wang, A., Chen, F., Xie, Y.J., Guo, Z. and Yu, Y.X. (2012) Protective Mechanism of Nicorandil on Rat Myocardial Ischemia-Reperfusion. Journal of Cardiovascular Medi-cine, 13, 511-515. [Google Scholar] [CrossRef]
|
|
[39]
|
Gregorini, L., Marco, J., Farah, B., et al. (2002) Effects of Selective α1- and α2-Adrenergic Blockade on Coronary Flow Reserve after Coronary Stenting. Circulation, 106, 2901-2907. [Google Scholar] [CrossRef]
|
|
[40]
|
张志引, 杨冯静, 张明玺. 冠状动脉慢血流中医治疗新进展[J]. 山西中医, 2022, 38(6): 68-70.
|
|
[41]
|
陈艳俏, 程伟, 张成英, 等. 保元汤合桂枝茯苓丸治疗冠状动脉慢血流临床观察[J]. 中国中医药现代远程教育, 2020, 18(19): 70-73.
|
|
[42]
|
Guo, H., Li, X. and Zhu, M. (2022) Me-ta-Analysis and Trial Sequential Analysis of Shexiang Baoxin Pill for Coronary Slow Flow. Frontiers in Pharmacology, 13, Article 955146. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
邵洁, 崔光卫, 戎靖枫, 等. 针刺郄门穴治疗冠状动脉慢血流现象的即刻疗效观察[J]. 上海中医药杂志, 2022, 56(1): 63-66.
|
|
[44]
|
李蒙, 李金根, 刘佳, 等. 麝香通心滴丸改善冠状动脉慢血流的研究进展[J]. 世界中医药, 2022, 17(8): 1180-1183.
|
|
[45]
|
姜海兵, 翟雪芹, 陈战西, 等. 芪红散联合尼可地尔治疗冠状动脉慢血流随机对照研究[J]. 中国中西医结合杂志, 2021, 41(10): 1174-1178.
|
|
[46]
|
苏立杰, 黄宇, 姚轶立, 等. 宽胸气雾剂对冠状动脉慢血流的即时作用效果[J]. 中西医结合心脑血管病杂志, 2021, 19(15): 2584-2588.
|